The central problem in variant evidence management is not the total number of records in ClinVar. It is whether the laboratory can recover the reasoning behind a prior classification when that reasoning is needed again.
Many laboratories already store classifications and applied ACMG/AMP criteria in a variant database or interpretation platform. A signed report communicates the approved conclusion, while those systems may retain the detailed assessment. Reuse becomes difficult when the linked records do not preserve a recoverable account of the evidence reviewed, source versions, applicable rules, clinical context, and rationale behind the decision.
- Prior internal classification
- Likely pathogenic
- Last evaluation
- 18 months ago
- Final report available
- Yes
- Original evidence packet retrievable
- Partial
- Applied ACMG/AMP criteria recoverable
- Yes
- Evidence-source versions recoverable
- No
- Disease-context scope stated
- No
- Prior reviewer rationale recoverable
- Partial
- New external evidence assessed
- Unknown
- Safe reuse decision
- Pending review
The classification is present. The institutional reasoning is incomplete.
Variant evidence management gives a laboratory the ability to preserve, retrieve, evaluate, and reuse its clinical reasoning under controlled review. That capability becomes critical when a previously classified variant appears in a new case, a public assertion changes, a clinician questions a result, or a reanalysis program expands.
Reuse Audit Record 01: Final Classifications Do Not Preserve Full Clinical Reasoning
A signed report is a patient-care artifact. It communicates an approved conclusion for a defined patient, indication, and reporting moment. It is not designed to preserve every source record, rejected line of evidence, data-release version, review discussion, or criterion-level rationale needed for future use.
Where detailed criteria and evidence are already held in a variant database, the internal workflow should link the issued report to the reviewed assessment. The full evidence packet does not need to be duplicated in the patient-facing report; it needs to remain recoverable from the laboratory’s interpretation records.
The ACMG/AMP framework for sequence-variant interpretation uses five classification categories: pathogenic, likely pathogenic, variant of uncertain significance, likely benign, and benign. It weighs evidence from population data, computational evidence, functional studies, segregation, and other relevant observations.
A future reviewer usually needs more than the final category. The reusable record should show the variant representation, gene-disease and inheritance context, source material reviewed, source dates or versions, ACMG/AMP criteria considered, applied strengths, reviewer rationale, approval history, and relationship to reports or amendments.
When those records are dispersed across reports, analyst notes, shared folders, and personal workspaces, the laboratory repeats reasoning it has already performed. It also becomes harder to determine whether a new publication, ClinVar submission, or internal observation is material to an earlier conclusion.
Connect interpretation, clinical review, reporting, and reusable knowledge.
NonStop engineers clinically governed genomics workflows that connect evidence assembly, review, reporting, and the data assets required to make interpretation work durable.
Reuse Audit Record 02: Evidence Without Variant Provenance Cannot Be Reliably Reused
A PubMed link without the reviewed claim, a ClinVar record without its review status, or an internal case note without phenotype context may be stored in the system. That does not make it reusable evidence.
The evidence record needs to preserve both the source and the laboratory’s assessment of the source.
- Identity
- Canonical identifier, genome build, HGVS, transcript, protein effect
- Context
- Gene, disease, inheritance model, relevant phenotype or assay scope
- Source
- Publication, ClinVar record, population dataset, functional study, or internal observation
- Source state
- Publication date, database release, record version, retrieval date
- Assessment
- ACMG/AMP criterion, applicable specification, applied strength, rationale
- Review
- Analyst, approver, review date, decision state
- Reuse boundary
- Context in which the assessment may be reused
The ClinGen Criteria Specification Registry maintains gene- and disease-specific specifications that refine application of ACMG/AMP evidence criteria. A provenance-aware record must therefore capture more than “PS3 applied” or “PM2 applied.” It needs the evidence item, source state, applicable specification, clinical context, assessment rationale, and reviewer decision.
Reuse Audit Record 03: Internal Precedent Is a Retrieval Signal, Not a Classification Shortcut
“We saw this variant before” should trigger retrieval, not end the review.
A previous internal assertion may have been made for another disease, phenotype, inheritance model, transcript policy, assay reportable range, evidence set, ACMG/AMP specification, or reporting policy. The molecular change may match, while the clinical decision does not.
A controlled knowledge record separates two tasks:
- What did the laboratory conclude previously?
- Which evidence, context, policy version, and approval supported it?
- Has the assertion been superseded, amended, or flagged for review?
- Does the current case fit the prior assertion’s defined scope?
- Has external or internal evidence changed?
- Do current assay, transcript, indication, or policy conditions alter applicability?
This is the operating point of clinical variant knowledge management. Historical decisions remain valuable, but they remain linked to their original scope and evidence. They are not promoted to automatic answers.
ClinVar aggregates submitted relationships between human variation and health, but its variant-level pages retain records from different submitters, conditions, and evaluations. The ClinVar VCV record model is useful for seeing why one matching public classification cannot replace a laboratory’s contextual assessment.
Reuse Audit Record 04: ClinVar Evidence Tracking Must Create a Reanalysis Work Item
ClinVar’s review-status model differentiates submissions with no stated criteria from assertions with criteria provided by a single submitter, multiple submitters without conflict, expert-panel review, and practice guidelines.
A “criteria provided, single submitter” assertion requires the submitter to provide a comprehensive evidence review consistent with current practice, state the criteria used, and provide supporting evidence or rationale, or identify a public contact who can supply it. Those expectations are defined in the ClinVar submission review guidelines.
These signals should create a controlled reanalysis workflow, not disappear into email alerts.
- Change event
- New ClinVar expert-panel assertion
- Affected internal assertion
- Internal assertion ID and canonical variant ID
- Current internal classification
- Likely pathogenic
- External change
- Condition-specific assertion differs from current internal scope
- Affected reported cases
- Identified by approved policy
- Required action
- Interpretation lead review
- Outcome
- Retained, revised, escalated, or no action
- Report amendment
- Determined by qualified clinical and laboratory leadership
The queue should also receive relevant literature, population-data updates, gene-disease validity changes, internal segregation or phenotype data, transcript-policy changes, and laboratory-policy updates. Qualified laboratory and clinical leaders remain responsible for reclassification, report amendments, and provider or patient communications. The workflow system preserves the evidence trail, prioritization, ownership, and audit record.
Reuse Audit Record 05: Automation Can Retrieve Evidence Without Replacing Clinical Judgment
Automation can normalize variant representations, retrieve sources, compare external records, detect changes, identify prior internal assertions, assemble evidence packets, and prioritize review queues.
Those capabilities do not remove the need for qualified review of whether evidence meets a criterion, whether a prior assertion applies to a new case, whether a classification should change, or whether a report amendment is appropriate.
Where generative AI is used to draft an evidence summary, label the output as AI-generated and retain links to the underlying sources. The workflow should preserve the relevant model/version information, draft date, and reviewer edits or approval. The qualified reviewer checks the summary against the original evidence; an AI-generated summary is not an independent source of clinical evidence.
| Automation may support | Qualified clinical review determines |
|---|---|
| Variant normalization and identity matching | Whether the match is clinically applicable in the current context |
| Evidence retrieval and comparison | Whether evidence meets the applicable ACMG/AMP criterion and strength |
| ClinVar and literature monitoring | Whether a change materially affects an internal assertion |
| Prior-precedent retrieval | Whether prior context matches the current disease, inheritance, assay, and patient context |
| AI-generated draft evidence summaries, where used | Whether the AI-generated summaries accurately reflect the cited sources and are complete and clinically appropriate |
| Queue prioritization | Whether to classify, reclassify, amend, report, or communicate |
The ACMG/AMP guideline states that clinical interpretation should include evidence supporting the classification and consider whether the finding may explain the patient’s indication for testing. That requirement places patient context and professional judgment at the center of the process, even when automated systems improve evidence retrieval and review preparation. Read the ACMG/AMP guideline.
A governed workflow directs automation toward retrieval, normalization, comparison, and prioritization. Qualified professionals retain responsibility for classification, reportability, patient-specific relevance, approval, and downstream action.
Build structured interpretation workflows around evidence and review.
Varion supports clinical variant-analysis workflows, evidence assembly, review queues, and controlled handoffs from tertiary analysis into clinical reporting.
The Variant Evidence Reuse Decision Has Four Outcomes
A prior internal classification does not require a binary choice between reuse and full reinterpretation. A controlled workflow can record four outcomes.
| Outcome | Meaning | Required record |
|---|---|---|
| Reuse within defined scope | Identity, approved evidence, context, and policy align with the defined reuse boundary | Scope match, retrieval date, and reviewer confirmation where required |
| Reuse after targeted confirmation | Prior reasoning remains relevant, but a source refresh or limited review is needed | Focused review, updated sources, and approval |
| Full reassessment | New evidence, context, policy, or uncertainty could alter the assertion | New assessment version linked to prior evidence and assertion history |
| Do not reuse | Identity, provenance, context, rationale, or policy alignment is insufficient | New interpretation with the prior assertion retained as historical context |
This approach prevents unnecessary reinvention when a provenance-rich assertion remains applicable. It also prevents teams from treating incomplete precedent as a shortcut.
A Reusable Clinical Variant Assertion Is a Defined Knowledge Object
A reusable assertion needs identity, evidence, assessment, and assertion states.
Coordinates, reference sequence, HGVS, gene, transcript, molecular consequence, VRS or other canonical identifier
Source, source version or release, source and retrieval dates, evidence type, context, limitations
ACMG/AMP criterion, applicable specification or policy version, applied strength, rationale, reviewer, approver, review state
Classification, condition and inheritance scope, reportability, effective date, supersession history, linked reports or amendments, monitoring rule
The GA4GH Variation Representation Specification provides a computational framework for representing genomic variation consistently and assigning globally unique computed identifiers. VRS v2.0 added standardized descriptions intended to support integration of variant evidence across sequence collections and resources.
A canonical identifier does not replace HGVS notation, transcript-aware interpretation, disease context, or clinical judgment. It gives a laboratory a stable technical handle for linking evidence, assertions, reports, and external updates that might otherwise be stored under incompatible representations.
What NonStop Engineers Around Reusable Variant Knowledge
Durable clinical variant knowledge management connects the laboratory’s existing variant database, evidence records, review decisions, and reporting history.
It is a connected operating system for evidence, review, approval, reuse, reanalysis, and reporting.
NonStop engineers that operating system through two connected capabilities.
- Varion supports clinical variant-analysis workflows, review queues, evidence assembly, and controlled movement from tertiary analysis into clinical reporting. NonStop describes Varion as building on a shared GA4GH VRS store with GENVAR and feeding approved results to reporting.
- GENVAR turns a laboratory’s classifications into a versioned, queryable knowledge base on a GA4GH VRS store and includes ClinVar diff monitoring.
- Clinical reporting engineering connects an approved assertion to report content, sign-out, structured result fields, amendments, and downstream delivery.
- Data engineering and platform engineering establish the canonical data model, evidence-ingestion pathways, change monitoring, access controls, audit records, and interfaces required for a client-owned knowledge asset.
- Forward-deployed engineering works with interpretation, laboratory, and technology teams in the real workflow: mapping evidence sources, defining assertion scope, designing review queues, connecting reporting, and transferring durable operational control to the laboratory.
The objective is not to automate medical judgment.
It is to make the laboratory’s validated reasoning accessible, reviewable, and reusable under the governance that clinical work requires.
Build an owned, versioned clinical variant knowledge base.
GENVAR provides the knowledge layer for reusable classifications, evidence provenance, internal precedent, ClinVar change monitoring, and controlled reanalysis workflows.
Assess Whether Your Variant Classifications Are Reusable Knowledge
NonStop’s Variant Knowledge Architecture Review maps how variant identity, ACMG evidence management, ClinVar tracking, internal precedent, clinical review, reanalysis, reporting, and audit records currently connect.
The review identifies:
- Classification rationale trapped in reports, spreadsheets, PDFs, or individual analysts’ workspaces
- Evidence records that lack source, date, version, context, or reviewer provenance
- ClinVar and literature changes that do not create controlled reassessment queues
- Internal precedent that cannot be reused safely because its original context is unclear
- Gaps between approved classifications, report templates, structured results, and amendment workflows
- A phased architecture for a client-owned clinical variant knowledge base

